LORI MORROW: Open Payments
NPI 1942587449 · SAINT JOHN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 13 payments from 9 companies in 2025. Trend: 2023 $214 · 2024 $121 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $100 |
| ARGENX US, INC. | 1 | $95 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $38 |
| Abbott Laboratories | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: VOQUEZNA, VYVGART, PIFELTRO, GVOKE HYPOPEN, FREESTYLE LIBRE 3, REXULTI, MOUNJARO, OPSUMIT.
Industry payments across IN — which companies pay providers there.
